BioCentury
ARTICLE | Management Tracks

FDA vet Singh joining CRDO Precision for Medicine

Plus: de Moerlooze to depart Bavarian and updates from Engitix, Actio and Oruka

May 22, 2024 11:32 PM UTC

Precision for Medicine Inc. said FDA veteran Harpreet Singh has become CMO of the biomarker-driven clinical research and development services company. At FDA, Singh was director of the Division of Oncology 2 and co-leader of Project Pragmatica, which seeks to improve efficiencies in clinical trial procedures and enhance patient centricity using real-world routine clinical practice. 

Laurence de Moerlooze will depart  Bavarian Nordic A/S (CSE:BAVA; Pink:BVNRY) as EVP and CMO to pursue new opportunities. The Danish company will begin a search for a successor. ...